Looking at the universe of stocks we cover at Dividend Channel, on 12/11/13, Concurrent Computer Corp. (CCUR) will trade ex-dividend, for its quarterly dividend of $0.12, payable on 12/27/13. As a percentage of CCUR's recent stock price of $7.72, this dividend works out to approximately 1.55%, so look for shares of Concurrent Computer Corp. to trade 1.55% lower — all else being equal — when CCUR shares open for trading on 12/11/13.Below is a dividend history chart for CCUR, showing historical dividends prior to the most recent $0.12 declared by Concurrent Computer Corp.: In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CCUR is likely to continue, and whether the current estimated yield of 6.22% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of CCUR shares, versus its 200 day moving average: Looking at the chart above, CCUR's low point in its 52 week range is $5.09 per share, with $8.95 as the 52 week high point — that compares with a last trade of $7.72. In Monday trading, Concurrent Computer Corp. shares are currently up about 1.6% on the day.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
What Every Investor Needs to Know: Cramer's 'Mad Money' Recap (Monday 6/24/19)
Jim Cramer explains the ins and outs of essential economic and investing lessons that every stock investor needs to know.
The Weak Dollar Is the Main Force in the Market Right Now
Gold continues to run higher as the dollar continues to collapse.
Stocks End Mixed as Wall Street Looks to G-20 Summit for U.S.-China Trade Talks
Stocks end little changed Monday as investors look to the upcoming G-20 summit for a breakthrough in talks between the world's two largest economies.
Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
About 6 million women suffer from hypoactive sexual desire disorder, which Palatin's Vyleesi is designed to treat.